{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:49:52Z","timestamp":1757314192842},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,26]]},"DOI":"10.7759\/cureus.67834","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T17:39:21Z","timestamp":1724693961000},"source":"Crossref","is-referenced-by-count":1,"title":["Palliative Care for Patients With Breast Cancer in a Palliative Care Unit of a Japanese Hospital"],"prefix":"10.7759","author":[{"given":"Bunzo","family":"Nakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Sakimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashige","family":"Tendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Tsukida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref2","unstructured":"Cancer statistics in Japan 2024. (2024). https.\/\/ganjoho.jp\/public\/qa_links\/report\/statistics\/2024_en.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e3283612241","article-title":"Palliative care in Japan: a review focusing on care delivery system","volume":"7","author":"Morita T","year":"2013","unstructured":"Morita T, Kizawa Y. Palliative care in Japan: a review focusing on care delivery system. Curr Opin Support Palliat Care. 2013, 7:207-15. 10.1097\/SPC.0b013e3283612241","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref4","unstructured":"Survey of medical institutions. (2020). https.\/\/www.mhlw.go.jp\/english\/database\/db-hss\/dl\/05_Outline_of_Results_Survey_of_Medical_Institutions_2020.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Gradishar WJ","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al.. Breast cancer, version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024, 22:331-57. 10.6004\/jnccn.2024.0035","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent R","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, et al.. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007, 13:4429-34. 10.1158\/1078-0432.CCR-06-3045","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni MM","year":"2015","unstructured":"Zamboni MM, da Silva CT Jr, Baretta R, Cunha ET, Cardoso GP. Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med. 2015, 15:29. 10.1186\/s12890-015-0025-z","journal-title":"BMC Pulm Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1554969","article-title":"Making cold malignant pleural effusions hot: driving novel immunotherapies","volume":"8","author":"Murthy P","year":"2019","unstructured":"Murthy P, Ekeke CN, Russell KL, et al.. Making cold malignant pleural effusions hot: driving novel immunotherapies. Oncoimmunology. 2019, 8:e1554969. 10.1080\/2162402X.2018.1554969","journal-title":"Oncoimmunology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14740\/wjon762w","article-title":"Obstructive jaundice as an uncommon manifestation of metastatic breast cancer","volume":"6","author":"Budimir I","year":"2015","unstructured":"Budimir I, Sabol Pusic M, Nikolic M, et al.. Obstructive jaundice as an uncommon manifestation of metastatic breast cancer. World J Oncol. 2015, 6:297-300. 10.14740\/wjon762w","journal-title":"World J Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpge.2016.03.001","article-title":"Ampullary metastasis from breast cancer: a rare cause of obstructive jaundice","volume":"23","author":"Giestas S","year":"2016","unstructured":"Giestas S, Lopes S, Souto P, Agostinho C, Camacho E, Cipriano M, Sofia C. Ampullary metastasis from breast cancer: a rare cause of obstructive jaundice. GE Port J Gastroenterol. 2016, 23:300-3. 10.1016\/j.jpge.2016.03.001","journal-title":"GE Port J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(93)90109-2","article-title":"Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin","volume":"72","author":"Sakuragawa N","year":"1993","unstructured":"Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M. Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin. Thromb Res. 1993, 72:475-500. 10.1016\/0049-3848(93)90109-2","journal-title":"Thromb Res"},{"key":"ref12","article-title":"Disseminated intravascular coagulation in patients with solid tumors","volume":"29","author":"Feinstein DI","year":"2015","unstructured":"Feinstein DI. Disseminated intravascular coagulation in patients with solid tumors. Oncology. 2015, 29:96-102.","journal-title":"Oncology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-022-01565-9","article-title":"Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases","volume":"8","author":"Hashizume S","year":"2022","unstructured":"Hashizume S, Shimoda M, Yoshinami T, et al.. Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases. Surg Case Rep. 2022, 8:210. 10.1186\/s40792-022-01565-9","journal-title":"Surg Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121051","article-title":"Hypercalcemia in cancer: causes, effects, and treatment strategies","volume":"13","author":"Bartkiewicz P","year":"2024","unstructured":"Bartkiewicz P, Kunachowicz D, Filipski M, Stebel A, Ligoda J, Rembia\u0142kowska N. Hypercalcemia in cancer: causes, effects, and treatment strategies. Cells. 2024, 13:1051. 10.3390\/cells13121051","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2113128","article-title":"Cancer-associated hypercalcemia","volume":"386","author":"Guise TA","year":"2022","unstructured":"Guise TA, Wysolmerski JJ. Cancer-associated hypercalcemia. N Engl J Med. 2022, 386:1443-51. 10.1056\/NEJMcp2113128","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.32768\/abc.2023104320-322","article-title":"Palliative sedation: responding to severe suffering in a metastatic breast cancer patient","volume":"10","author":"Tahmasebi M","year":"2023","unstructured":"Tahmasebi M, Shamsi-Gooshki E. Palliative sedation: responding to severe suffering in a metastatic breast cancer patient. Arch Breast Cancer. 2023, 10:320-2. 10.32768\/abc.2023104320-322","journal-title":"Arch Breast Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165187","article-title":"Survival outcomes in palliative sedation based on referring versus on-call physician prescription","volume":"12","author":"Lojo-Cruz C","year":"2023","unstructured":"Lojo-Cruz C, Mora-Delgado J, Rivas Jim\u00e9nez V, Carmona Espinazo F, L\u00f3pez-S\u00e1ez JB. Survival outcomes in palliative sedation based on referring versus on-call physician prescription. J Clin Med. 2023, 12:5187. 10.3390\/jcm12165187","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/287166-palliative-care-for-patients-with-breast-cancer-in-a-palliative-care-unit-of-a-japanese-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T17:39:27Z","timestamp":1724693967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/287166-palliative-care-for-patients-with-breast-cancer-in-a-palliative-care-unit-of-a-japanese-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.67834","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,26]]}}}